| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.92B | $2.61B | $2.26B |
| YoY Revenue Growth % | +11.8% | +15.3% | — |
| Gross Profit | $2.26B | $1.99B | — |
| Gross Margin % | 77.4% | 76.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $149.0M | -$74.0M | -$516.0M |
| Operating Margin % | 5.1% | -2.8% | -22.8% |
| Net Income (GAAP) | $235.0M | $28.0M | -$355.0M |
| EBITDA (Normalized) | $156.2M | -$67.6M | -$434.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $884.0M | $750.0M | $512.0M |
| Capital Expenditures (CapEx) | $9.0M | $8.0M | $101.8M |
| Free Cash Flow (FCF) | $875.0M | $742.0M | $410.2M |
| FCF Margin % | 30.0% | 28.4% | 18.1% |
| Return on Invested Capital (ROIC %) | 1.6% | -0.8% | -3.2% |
| Cash & Short-Term Equivalents | $858.0M | $409.0M | — |
| Total Debt (Short + Long Term) | $1.22B | $1.36B | $4.99B |
| Total Stockholders' Equity | $7.00B | $6.41B | $10.24B |